BiotechTube

basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroids

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pediatric Kidney Transplantation

Conditions

Pediatric Kidney Transplantation

Trial Timeline

May 1, 2001 → —

NCT ID
NCT00228020

About basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroids

basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroids is a phase 3 stage product being developed by Novartis for Pediatric Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00228020. Target conditions include Pediatric Kidney Transplantation.

What happened to similar drugs?

3 of 18 similar drugs in Pediatric Kidney Transplantation were approved

Approved (3) Terminated (0) Active (15)
✅Boosted AtazanavirBristol Myers SquibbApproved
✅Atazanavir + RitonavirBristol Myers SquibbApproved
✅IgPro10CSLApproved
🔄candsartan cilexetilAstraZenecaPhase 3
🔄VAL489 + VAL489 matching placeboNovartisPhase 3
🔄Entecavir + Lamivudine + Pegylated Interferon Alfa-2ARochePhase 3
🔄EtanerceptAmgenPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00228020Phase 3Completed

Competing Products

20 competing products in Pediatric Kidney Transplantation

See all competitors
ProductCompanyStageHype Score
RamucirumabEli LillyPhase 1
29
erlotinib + etoposideAstellas PharmaPhase 2
27
Mitoxantrone Hydrochloride Liposome + Irinotecan + VincristineSun PharmaceuticalPhase 1
33
Perampanel Oral Suspension + Perampanel TabletEisaiPhase 2
42
Eribulin MesylateEisaiPhase 1
29
Decitabine + DecitabineEisaiPhase 2
27
Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once dailySumitomo PharmaPhase 1
29
Remimazolam Tosilate for injection + Propofol InjectionJiangsu Hengrui MedicinePhase 2/3
45
Ceftaroline fosamil + Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam + Cephalexin or Clindamycin or LinezolidAstraZenecaPhase 2/3
38
candsartan cilexetilAstraZenecaPhase 3
40
Durvalumab / Tremelimumab Combination TherapyAstraZenecaPhase 1/2
36
Rotavirus VaccineMerckPre-clinical
18
VAL489 + VAL489 matching placeboNovartisPhase 3
40
LCZ696 + Enalapril + Placebo of LCZ696 + Placebo of Enalapril + LCZ696NovartisPhase 2/3
38
EverolimusNovartisPhase 2
35
Corticosteroids + Cyclosporine + mycophenolate mofetilRochePhase 2
27
Entecavir + Lamivudine + Pegylated Interferon Alfa-2ARochePhase 3
40
Blinatumomab for InjectionAmgenPhase 1
25
EtanerceptAmgenPhase 3
40
DenosumabAmgenPhase 3
40